Production & Manufacturing
Press Releases
Sterling Pharma Solutions invests $1.5m into US facility expansion
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing $1.5m into a phased expansion of its US facility in North Carolina.
The investment follows the acquisition of the former US CiVentiChem site earlier this year. Over the...
Press Releases
Covance Unveils New R&D Center in Shanghai
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that its Covance Drug Development business celebrated the opening of its new R&D Center in Shanghai, China, which is now its largest facility...
Clinical Trials
Sharp’s Netherlands Facility Approved for Clinical Operations
Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and Investigational Medicinal Product (IMP) licensing approvals to support clinical activities from its facility in Heerenveen,...
Press Releases
Sterling commences large-scale production of Nanologica’s silica particles
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has started large-scale production of Nanologica’s silica particles.
Nanologica is a nanotechnology company specialising in the development of silica for application in drug development and chromatography.
The company recently signed a...
Press Releases
Ardena Group launches Life Science Ingredients arm
Contract development and manufacturing organization (CDMO) Ardena has launched Ardena LSI, a new arm of its business dedicated to the sale of chemical ingredients and intermediates for the life science industry.
Ardena LSI will manufacture chemical ingredients for the development...
Press Releases
Catalent Biologics Announces Agreement To Provide Additional Production Of Approved Gene Therapy Treatment For Spinal Muscular Atrophy
Catalent Biologics announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for spinal muscular atrophy (SMA).
Through this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space at the...
News
FUJIFILM Irvine Scientific Announces Construction of a New Cell Culture Media Manufacturing Site in Europe
FUJIFILM Irvine Scientific, Inc., a global leader in the innovation, development, and manufacture of cell culture media, announced plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















